We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Radical Changes Seen in Future Laboratory Testing

By HospiMedica staff writers
Posted on 22 Aug 2001
A new process that enables individuals to order and view laboratory tests privately on the Internet, and the rapid growth of new tests and methods based on genomic research, are part of the sea change that will dramatically alter the practice of laboratory testing, according to Bruce A. More...
Friedman, professor of pathology, University of Michigan Medical School (Ann Arbor, USA). Dr. Friedman made his observations at the Annual Meeting of the American Association for Clinical Chemistry in Chicago, IL (USA).

Direct Access Testing (DAT) allows patients on their own, without physician intervention, to order, pay for, and obtain test results anonymously on the Internet. The process has already been put into practice by a large U.S. laboratory, which has opened storefront clinics in four states permitting people to order their own tests without the need for a doctor's order. Dr. Friedman said many people will use DAT because it offers confidentiality to those who fear their health information could be made available to employers or others. Within five years, he predicted, 10% or more of all lab testing will be done by DAT.

At the same time, Dr. Friedman expects the number of conventional laboratory tests to skyrocket. He also foresees new testing methods that will allow for the development of more numerous and more complex lab tests. Perhaps as many as 200 tests could become the norm when a patient is admitted to a hospital. Outpatient testing will become more complex and challenging in terms of result interpretation, requiring computers to arrive at the proper diagnosis and therapy.

Dr. Friedman also expects that some health-care providers may find it economically beneficial to give patients "lab test accounts.” These would allow patients with diseases such as chronic anemia or liver disease to order their own tests whenever they want, and thereby monitor their disease. Another new practice, pioneered at the University of Pittsburgh Medical Center (PA, USA), is the development of a system that allows pathologists to post surgical biopsy images online for clinicians to review and share their visual findings with patients via the website.




Related Links:
American Association for Clinical Chemistry

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
PACS Workstation
PaxeraView PRO
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.